Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial

Journal:

Nature Communications

Published:

2025-12-21

DOI:

10.1038/s41467-025-67375-3

Affiliations:

31

Authors:

36

Go to article

Institutions	Authors	Share
HUTCHMED, China	7.000000	0.19
Fudan University Shanghai Cancer Center (FUSCC), China	1.000000	0.03
Hunan Cancer Hospital, China	1.000000	0.03
Liaoning Cancer Hospital and Institute, China	1.000000	0.03
Wuhan Union Hospital, HUST, China	1.000000	0.03
Guangxi Medical University, China	1.000000	0.03
Henan Cancer Hospital, ZZU, China	1.000000	0.03
Cancer Hospital of Yunnan Province, China	1.000000	0.03
Hospital and Cancer Center, CQU, China	1.000000	0.03
Tianjin Medical University Cancer Institute and Hospital, TMU, China	1.000000	0.03
Beijing Obstetrics and Gynecology Hospital, Capital Medical University, China	1.000000	0.03
Xiangyang Central Hospital, China	1.000000	0.03
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China	1.000000	0.03
Hubei Cancer Hospital (HBCH), China	1.000000	0.03
Harbin Medical University Cancer Hospital, China	1.000000	0.03
Second Affiliated Hospital of Nanjing Medical University, China	1.000000	0.03
The Second Hospital of Dalian Medical University, China	1.000000	0.03
The First Affiliated Hospital of Xi'an Jiaotong University, XJTU, China	1.000000	0.03
Linyi Cancer Hospital, China	1.000000	0.03
The First Affiliated Hospital, USTC, China	1.000000	0.03
Henan Provincial People's Hospital, China	1.000000	0.03
Renmin Hospital of Wuhan University/Hubei General Hospital, China	1.000000	0.03
Qilu Hospital of Shandong University, China	1.000000	0.03
Obstetrics and Gynecology Hospital, Fudan University, China	1.000000	0.03
The First Affiliated Hospital of Bengbu Medical University, China	1.000000	0.03
Affiliated Hospital of Nantong University, China	1.000000	0.03
The Second Affiliated Hospital to Nanchang University, China	1.000000	0.03
Yantai Yuhuangding Hospital, China	1.000000	0.03
The Second Clinical Hospital of Jilin University, China	1.000000	0.03
Zhejiang Cancer Hospital (ZJCH), China	0.500000	0.01
University of Chinese Academy of Sciences (UCAS), China	0.500000	0.01

Interested in Oncology and Carcinogenesis?